
Caplin Steriles Gets USFDA Approval for Calcium Gluconate Injection
Chennai: Caplin Steriles Limited (CSL), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Calcium Gluconate Injection USP (100 mg/mL in 10 mL, 50 mL and 100 mL Vials), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) from Fresenius Kabi USA, LLC (NDA 208418). Calcium Gluconate Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. According











































